Outset Medical (OM) Short-term Investments (2019 - 2026)

Outset Medical (OM) has reported Short-term Investments for 8 consecutive years, with $126.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments rose 11.56% year-over-year to $126.1 million; the TTM figure through Mar 2026 stood at $126.1 million (up 11.56% YoY), while the FY2025 annual figure was $133.9 million, up 286.32% from the prior year.
• Short-term Investments fell to $126.1 million in Q1 2026 per OM's latest filing, from $133.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $214.3 million in Q4 2022 and bottomed at $34.7 million in Q4 2024.
• Historically, Short-term Investments has averaged $154.9 million across 5 years, with a median of $157.0 million in 2024.
• Annual changes were most pronounced in 2022 — Short-term Investments surged 630.73% — and 2024, when it plunged 74.28%.
• Outset Medical's Short-term Investments stood at $214.3 million in 2022, then sank by 37.08% to $134.8 million in 2023, then slumped by 74.28% to $34.7 million in 2024, then surged by 286.32% to $133.9 million in 2025, then declined by 5.82% to $126.1 million in 2026.
• Business Quant data shows OM's Short-term Investments at $126.1 million in Q1 2026, $133.9 million in Q4 2025, and $142.2 million in Q3 2025.